What it is used for

APTIVUS (tipranavir), co-administered with low dose ritonavir, is indicated for combination treatment of HIV infection in antiretroviral treatment experienced patients from 2 years of age, with evidence of viral replication, who have HIV-1 strains resistant to more than one protease inhibitor. In deciding to initiate therapy with APTIVUS/ritonavir, careful consideration should be given to treatment history of the individual patient and the patterns of mutations associated with different agents. Genotypic testing should be performed to guide the use of APTIVUS. There are insufficient data in paediatric patients less than 2 years of age and treatment of these children with APTIVUS is therefore not recommended.

How to take it

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

• The way to take this medicine: Oral
• Store at 2 to 8 degrees Celsius
• Refrigerate
• Do not Freeze
• Shelf lifetime is 3 Years.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Pink, oblong, soft gelatin capsules imprinted in black with 'TPV 250'

Images are the copyright of the Pharmacy Guild of Australia

Do I need a prescription?

This medicine is available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine. open tool tip to find out more

Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November 1, 2018. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy?

For the active ingredient tipranavir

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.